Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Larimar Therapeutics Inc logo

Larimar Therapeutics Inc

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

7.30
 
USD
  
0.34
  
(4.89%)
Optionable: Yes  Market Cap: 449 M  90-day average vol: 625,640

Previous close: 6.96  Open: 6.96  Bid: 7.03  Ask: 7.35
52 week range    
2.18   
   13.68
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Tuesday 16th April 2024
42
MarketXLS Rank
60
Value
30
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

LRMR Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-3.57-2.95-1.37-0.84
Basic EPS total-3.57-2.95-1.37-0.84
Basic weighted shares outstanding3 M12 M17 M26 M44 M
Depreciation-78000.0155000.0
DepreciationAndAmortization-78000.0155000.0
Diluted EPS total-14.64-3.57-2.95-1.37-0.84
Diluted normalized net income/share-2.95-1.37-0.84
Diluted weighted shares outstanding3 M12 M17 M26 M44 M
GeneralAndAdministrativeExpense2 M11 M12 M12 M14 M
Gross operating profit112000.0
Income before tax-23 M-42 M-51 M-35 M-37 M
Income restructuring and M&A6 M
Interest income82000.0
InterestExpenseNonOperating2 M
MiscOtherSpecialCharges322000.0-171000.01 M5 M
Net income from total operations-23 M-42 M-51 M-35 M-37 M
NetIncomeCommonStockholders-23 M-42 M-51 M-35 M-37 M
NetIncomeContinuousOperations-23 M-42 M-51 M-35 M-37 M
NetNonOperatingInterestIncomeExpense82000.0
Normalized income-40 M-29 M
Operating income-23 M-43 M-50 M-37 M-42 M
Operating income before depreciation (EBITDA)-23 M-42 M-50 M-36 M-38 M
OperatingExpense-23 M43 M50 M37 M42 M
Other income net-100000.0-322000.0171000.0-1 M-5 M
OtherGandA2 M11 M12 M12 M14 M
OtherImpairmentOfCapitalAssets-100000.0
OtherOperatingExpenses-46 M700000.0300000.0300000.0400000.0
RentAndLandingFees2 M
Research & development expense21 M31 M38 M24 M28 M
ResearchExpense21 M31 M38 M24 M28 M
RestructringAndMnAIncome6 M
SalariesAndWages-129000.0
Selling Gen & administrative expense2 M11 M12 M12 M14 M
Special income/charges-6 M
Total Income available for interest expense (EBIT)-23 M-42 M-51 M-35 M-37 M
Total common shares outstanding3 M15 M18 M43 M64 M
Total net income-23 M-42 M-51 M-35 M-37 M
Total ordinary shares64 M64 M64 M64 M64 M
Total revenues112000.0
TotalExpenses-23 M43 M50 M37 M42 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University